Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study.
Authors: Pahwa R, Isaacson SH, Cella D, Thakkar S, Kandukuri PL, Yan CH, Kukreja P, Pan I, Lee J, Aldred J
Journal: Clinical parkinsonism & related disorders
acceptance commitment therapy
mental health
open access